ARID1A Gene Mental Retardation Autosomal Dominant Type 14 Genetic Test
At DNA Labs UAE, we offer the ARID1A Gene Mental Retardation Autosomal Dominant Type 14 Genetic Test. This test is designed to diagnose and provide information about mental retardation, autosomal dominant type 14 (MRD14), a condition characterized by intellectual disability, developmental delay, and other neurological features.
Test Components
- Price: 4400.0 AED
Sample Condition
We accept blood samples, extracted DNA, or one drop of blood on an FTA card.
Report Delivery
Reports are typically delivered within 3 to 4 weeks.
Method
We use NGS technology for this genetic test. NGS, or next-generation sequencing, allows for the simultaneous analysis of multiple genes and provides quick and accurate sequencing of an individual’s DNA.
Test Type
This test is specifically designed for neurological disorders.
Doctor
This test is conducted by our experienced neurologists.
Test Department
This test falls under our Genetics department.
Pre Test Information
Prior to the test, we recommend providing the clinical history of the patient who is undergoing the ARID1A Gene Mental Retardation Autosomal Dominant Type 14 NGS Genetic DNA Test. We also offer a genetic counseling session to draw a pedigree chart of family members affected by MRD14.
Test Details
The ARID1A gene is associated with mental retardation, autosomal dominant type 14 (MRD14). This condition is characterized by intellectual disability, developmental delay, and other neurological features. Our NGS genetic testing allows for the identification of mutations or variants in the ARID1A gene that may be responsible for the condition. This testing can confirm a diagnosis, provide information about the genetic cause of the condition, and guide genetic counseling and management options for individuals and their families.
It is important to note that the ARID1A gene is also associated with various types of cancer. Therefore, the specific indication for ARID1A gene testing may vary depending on the clinical context and suspected diagnosis.
| Test Name | ARID1A Gene Mental retardation autosomal dominant type 14 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Neurological Disorders |
| Doctor | Neurologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for ARID1A Gene Mental retardation, autosomal dominant type 14 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with ARID1A Gene Mental retardation, autosomal dominant type 14 |
| Test Details | The ARID1A gene is associated with a condition called mental retardation, autosomal dominant type 14 (MRD14). This condition is characterized by intellectual disability, developmental delay, and other neurological features. NGS genetic testing, or next-generation sequencing genetic testing, is a type of genetic testing that allows for the simultaneous analysis of multiple genes. It uses advanced sequencing technology to quickly and accurately sequence an individual’s DNA. In the context of MRD14, NGS genetic testing can be used to identify mutations or variants in the ARID1A gene that may be responsible for the condition. This testing can help confirm a diagnosis, provide information about the genetic cause of the condition, and inform genetic counseling and management options for individuals and their families. It’s important to note that the ARID1A gene is associated with other conditions as well, including various types of cancer. Therefore, the specific indication for ARID1A gene testing may vary depending on the clinical context and suspected diagnosis. |
